USFDA gives tentative approval to Alembic Pharma’s acalabrutinib capsules, 100 mg
The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product, calquence capsules, 100 mg, of…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.